EvoNext Holdings SA (SWX:EVE)
Switzerland · Delayed Price · Currency is CHF 0.9980
+0.0880 (9.67%)
Apr 22, 2026, 1:38 PM CET
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of 7.2 million as of April 22, 2026. Its market cap has decreased by -20.16% in one year.
Market Cap
7.20M
Enterprise Value
884.13K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 392.12M to 7.20M, a decrease of -98.16%. That is a compound annual growth rate of -21.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 6.56M | 12.35% |
| Dec 30, 2025 | 5.84M | -10.00% |
| Dec 30, 2024 | 6.49M | 32.37% |
| Dec 29, 2023 | 4.90M | -94.61% |
| Dec 30, 2022 | 91.05M | -28.31% |
| Dec 30, 2021 | 127.00M | -19.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 930.57M |
| Basilea Pharmaceutica AG | 678.50M |
| Newron Pharmaceuticals | 341.22M |
| Santhera Pharmaceuticals Holding AG | 238.14M |
| BioVersys AG | 174.86M |
| Molecular Partners AG | 129.44M |
| Xlife Sciences AG | 124.00M |
| Addex Therapeutics | 5.48M |